ciprofloxacin has been researched along with ascorbic acid in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 23 (69.70) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| el-Gazzar, AB; Hafez, HN; Nawwar, GA | 1 |
| Gopalakrishnan, S; Manojkumar, P; Ravi, TK | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Lakshmi, NV; Noorulla, KM; Perumal, PT; Thirumurugan, P | 1 |
| Abdel-Wahab, BF; Awad, GE; Badria, FA | 1 |
| Abdu Musad, E; Mohamed, R; Rai, KM; Saeed, BA; Vishwanath, BS | 1 |
| Fronczek, FR; Indumathi, T; Jamal Ahamed, VS; Moon, SS; Rajendra Prasad, KJ | 1 |
| Dastan, SD; Karatepe, M; Koparir, M; Koparir, P; Orek, C; Parlak, AE; Söylemez, A | 1 |
| Harikrishna, N; Kotaiah, Y; Nagaraju, K; Venkata Rao, C; Vijjulatha, M; Yamini, L | 1 |
| Rajasekaran, A; Senthilkumar, P; Sivakumar, KK; Wattamwar, PP | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Kariyappa, AK; Nagamallu, R; Ningappa, MB; Srinivasan, B | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ajay Kumar, K; Kameshwar, VH; Raghavendra, KR; Renuka, N; Shashikanth, S; Srinivasan, B | 1 |
| Artym, J; Jeleń, M; Kocięba, M; Morak-Młodawska, B; Pluta, K; Zaczyńska, E; Zimecki, M | 1 |
| Arora, D; Bhushan, S; Gupta, P; Jaglan, S; Kumar, A; Kushwaha, M; Sharma, N; Sharma, V; Singamaneni, V | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
| Appel, RG; Cowan, RJ; Houston, TK; Peacock, JE | 1 |
| Kawachi, A; Miyashita, M; Motoya, T; Yamada, K | 1 |
| Goswami, M; Jawali, N; Mangoli, SH | 1 |
| Gorla, NB; Ovando, HG; Ugnia, LI; Weyers, A | 1 |
| Boushi, LA; Douri, TH; Shawaf, AZ | 1 |
| Isbaniah, F; Setiawati, A; Totzke, U; Verbruggen, MA; Wiyono, WH; Yunus, F | 1 |
| Kumar, A; Nain, J; Nain, P; Sharma, S | 1 |
| Al-Azzam, SI; Alzoubi, KH; Masadeh, MM; Mhaidat, NM; Shaweesh, AI | 1 |
| Ding, Y; Wei, Y; Zhang, X | 1 |
| Albesa, I; Angel Villegas, N; Baronetti, J; Becerra, MC; Etcheverría, A; Padola, NL; Paraje, MG | 1 |
| Audino, P; Cavallone, B; Di Stasio, A; Serao, A; Tiranti, D; Vota, P | 1 |
| Abbas, HA; Goda, RM; Kadry, AA; Shaker, GH | 1 |
| Mansour, HA; Masoud, MA; Sheded, MS; Yahia, R | 1 |
| Gębalski, J; Gospodarek-Komkowska, E; Kwiecińska-Piróg, J; Przekwas, J; Rutkowska, D; Skowron, K; Wałecka-Zacharska, E; Wiktorczyk-Kapischke, N | 1 |
| Bishayi, B; Dey, R | 1 |
4 review(s) available for ciprofloxacin and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Antipsychotic Agents; Bacteria; Fungi; Humans; Leishmania; Molecular Structure; Neoplasms; Phenothiazines | 2017 |
Gallium-67-citrate scanning of renal parenchymal malacoplakia.
Topics: Anti-Infective Agents; Ascorbic Acid; Ciprofloxacin; Citrates; Female; Gallium; Gallium Radioisotopes; Humans; Kidney Diseases; Malacoplakia; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rifampin | 1998 |
Perianal cutaneous malakoplakia in an immunocompetent patient.
Topics: Anti-Bacterial Agents; Anus Diseases; Anus Neoplasms; Ascorbic Acid; Ciprofloxacin; Combined Modality Therapy; Condylomata Acuminata; Diagnostic Errors; Drug Therapy, Combination; Humans; Immunocompetence; Macrophages; Malacoplakia; Male; Recurrence; Young Adult | 2010 |
1 trial(s) available for ciprofloxacin and ascorbic acid
| Article | Year |
|---|---|
Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ascorbic Acid; Ciprofloxacin; Disease Progression; Double-Blind Method; Drug Synergism; Echinacea; Female; Herb-Drug Interactions; Humans; Immunity, Innate; Male; Micronutrients; Middle Aged; Phytotherapy; Placebos; Plant Extracts; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Selenium; Treatment Outcome; Vitamins; Zinc | 2011 |
28 other study(ies) available for ciprofloxacin and ascorbic acid
| Article | Year |
|---|---|
New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines.
Topics: Analgesics; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; Bacteria; Carrageenan; Drug Discovery; Edema; Female; Lipid Peroxidation; Male; Mice; Microwaves; Nucleosides; Quinolines; Rats | 2009 |
Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety.
Topics: Anti-Bacterial Agents; Antioxidants; Bacillus subtilis; Coumarins; Free Radical Scavengers; Pyrazoles; Pyrazolones; Staphylococcus aureus; Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
Topics: Anti-Infective Agents; Antineoplastic Agents; Antioxidants; Catalysis; Cell Line, Tumor; Drug Evaluation, Preclinical; Humans; Indium; Indoles; Models, Molecular | 2010 |
Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antioxidants; Bacteria; Cell Proliferation; Drug Screening Assays, Antitumor; Erythrocytes; Hemolysis; Heterocyclic Compounds; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Rats; Stereoisomerism; Structure-Activity Relationship | 2011 |
Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles.
Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; Isoxazoles; Lipid Peroxidation; Magnetic Resonance Spectroscopy; Molecular Structure; Oxadiazoles; Pyrazoles | 2011 |
L-Proline anchored multicomponent synthesis of novel pyrido[2,3-a]carbazoles; investigation of in vitro antimicrobial, antioxidant, cytotoxicity and structure activity relationship studies.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Carbazoles; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Free Radical Scavengers; Fungi; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Proline; Structure-Activity Relationship | 2011 |
Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Aspergillus flavus; Aspergillus fumigatus; Biphenyl Compounds; Dose-Response Relationship, Drug; Escherichia coli; Free Radical Scavengers; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Oxidation-Reduction; Penicillium; Picrates; Staphylococcus aureus; Thiones; Triazoles; Trichophyton | 2013 |
Synthesis, docking and evaluation of antioxidant and antimicrobial activities of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazol-6-yl)selenopheno[2,3-d]pyrimidines.
Topics: Anti-Infective Agents; Antioxidants; Bacteria; Bacterial Infections; Benzene Derivatives; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses; Organoselenium Compounds; Pyrimidines; Thiadiazoles | 2014 |
Conventional and microwave assisted synthesis of pyrazolone Mannich bases possessing anti-inflammatory, analgesic, ulcerogenic effect and antimicrobial properties.
Topics: Acetic Acid; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bacteria; Carrageenan; Dose-Response Relationship, Drug; Edema; Mice; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Pain; Pyrazolones; Rats; Structure-Activity Relationship | 2014 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities.
Topics: Anti-Infective Agents; Antioxidants; Bacteria; Bacterial Infections; Coumarins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrazoles; Quantitative Structure-Activity Relationship | 2016 |
Synthesis of lignan conjugates via cyclopropanation: Antimicrobial and antioxidant studies.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Bacteria; Cyclopropanes; Dose-Response Relationship, Drug; Fungi; Lignans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2016 |
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ascomycota; Cell Line, Tumor; Cell Proliferation; Datura; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Conformation; Peptides, Cyclic; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Valproic Acid | 2018 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Effects of ascorbic acid on interactions between ciprofloxacin and ferrous sulphate, sodium ferrous citrate or ferric pyrophosphate, in mice.
Topics: Absorption; Administration, Oral; Animals; Anti-Infective Agents; Ascorbic Acid; Ciprofloxacin; Citric Acid; Diphosphates; Drug Interactions; Ferrous Compounds; Iron; Iron Compounds; Male; Mice | 2000 |
Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli.
Topics: Anti-Infective Agents; Antioxidants; Ascorbic Acid; Catalase; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Glutathione; Microbial Sensitivity Tests; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Superoxide Dismutase | 2006 |
Antioxidant capacity of vitamin C in mouse liver and kidney tissues.
Topics: Animals; Antioxidants; Ascorbic Acid; Ciprofloxacin; Diet; Female; Kidney; Lipid Peroxidation; Lipid Peroxides; Liver; Male; Mice; Mice, Inbred BALB C; Thiobarbituric Acid Reactive Substances | 2008 |
In vitro evaluation of antimicrobial and antioxidant activities of methanolic extract of Jasminum humile leaves.
Topics: Anti-Infective Agents; Antioxidants; Ascorbic Acid; Biphenyl Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Free Radicals; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Jasminum; Methanol; Picrates; Plant Extracts; Plant Leaves | 2011 |
Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Antagonism; Humans; Microbial Sensitivity Tests; Vitamin E | 2012 |
Electrocatalytic oxidation and voltammetric determination of ciprofloxacin employing poly(alizarin red)/graphene composite film in the presence of ascorbic acid, uric acid and dopamine.
Topics: Anthraquinones; Ascorbic Acid; Ciprofloxacin; Dopamine; Electrochemical Techniques; Graphite; Humans; Oxidation-Reduction; Uric Acid | 2014 |
Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Biofilms; Catalase; Cell Survival; Chlorocebus aethiops; Ciprofloxacin; Fosfomycin; Glutathione; Microbial Sensitivity Tests; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Rifamycins; Rifaximin; Shiga Toxin 1; Shiga Toxin 2; Shiga-Toxigenic Escherichia coli; Superoxide Dismutase; Vero Cells; Virulence Factors | 2015 |
Bilateral hydroureteronephrosis with renal failure caused by malacoplakia.
Topics: Aged; Anti-Bacterial Agents; Ascorbic Acid; Ciprofloxacin; Female; Humans; Hydronephrosis; Malacoplakia; Renal Insufficiency; Stents; Treatment Outcome; Urinary Bladder; Urinary Catheterization; Urinary Tract Infections; Vitamins | 2018 |
Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Catalytic Domain; Ciprofloxacin; Citric Acid; Drug Combinations; Drug Synergism; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Malates; Meropenem; Microbial Sensitivity Tests; Zinc | 2019 |
The possible neurobehavioral protective effects of natural antioxidant against phototoxicity attenuation of antimicrobial quinolone group in rats.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Behavior, Animal; Cerebrum; Ciprofloxacin; Dermatitis, Phototoxic; Escherichia coli; Escherichia coli Infections; Glutathione; Locomotion; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Ultraviolet Rays | 2020 |
The effect of fluoroquinolones and antioxidans on biofilm formation by Proteus mirabilis strains.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Biofilms; Ciprofloxacin; Fluoroquinolones; Humans; Norfloxacin; Proteus mirabilis; Rutin | 2022 |
Ascorbic acid along with ciprofloxacin regulates S. aureus induced microglial inflammatory responses and oxidative stress through TLR-2 and glucocorticoid receptor modulation.
Topics: Antioxidants; Ascorbic Acid; Ciprofloxacin; Hydrogen Peroxide; Methicillin-Resistant Staphylococcus aureus; Microglia; Oxidative Stress; Receptors, Glucocorticoid; Staphylococcus aureus | 2022 |